![Robert Sosnowski](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Robert Sosnowski
Keine laufenden Positionen mehr
Karriereverlauf von Robert Sosnowski
Ehemalige bekannte Positionen von Robert Sosnowski
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
CYCLACEL PHARMACEUTICALS, INC. | Vertrieb & Marketing | 30.06.2012 | 30.06.2012 |
Algos Pharmaceutical Corp.
![]() Algos Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Part of Endo International Plc, Algos Pharmaceutical Corp. develops and makes pain management products including narcotic drugs. The company is based in Neptune, NJ. Algos Pharmaceutical was acquired by Endo Health Solutions, Inc. on July 17, 2000 for $243.89 million. | Vertrieb & Marketing | - | - |
Dexgen Pharmaceuticals, Inc. | Gründer | 06.05.2011 | - |
Präsident | 01.01.2000 | - |
Ausbildung von Robert Sosnowski
University of Connecticut | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 5 |
Operativ
Sales & Marketing | 2 |
Undergraduate Degree | 1 |
Founder | 1 |
Sektoral
Health Technology | 3 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
CYCLACEL PHARMACEUTICALS, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Algos Pharmaceutical Corp.
![]() Algos Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Part of Endo International Plc, Algos Pharmaceutical Corp. develops and makes pain management products including narcotic drugs. The company is based in Neptune, NJ. Algos Pharmaceutical was acquired by Endo Health Solutions, Inc. on July 17, 2000 for $243.89 million. | Health Technology |
Dexgen Pharmaceuticals, Inc. |
- Börse
- Insiders
- Robert Sosnowski
- Erfahrung